These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 15738438)

  • 41. Alcohol research and the alcoholic beverage industry: issues, concerns and conflicts of interest.
    Babor TF
    Addiction; 2009 Feb; 104 Suppl 1():34-47. PubMed ID: 19133913
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Standard Operating Procedures, ethical and legal regulations in BTB (Brain/Tissue/Bio) banking: what is still missing?
    Ravid R
    Cell Tissue Bank; 2008 Jun; 9(2):121-37. PubMed ID: 17985213
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Essentials of research ethics for healthcare professionals.
    Aita M; Richer MC
    Nurs Health Sci; 2005 Jun; 7(2):119-25. PubMed ID: 15877688
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Moving from institutional dependence to entrepreneurialism. Creating and funding a collaborative research and practice development position.
    Darbyshire P; Downes M; Collins C; Dyer S
    J Clin Nurs; 2005 Sep; 14(8):926-34. PubMed ID: 16102144
    [TBL] [Abstract][Full Text] [Related]  

  • 45. How ethical is ethical research? Recruiting marginalized, vulnerable groups into health services research.
    Smith LJ
    J Adv Nurs; 2008 Apr; 62(2):248-57. PubMed ID: 18394037
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aligning academic and clinical missions through an integrated funds-flow allocation process.
    Kennedy DW; Johnston E; Arnold E
    Acad Med; 2007 Dec; 82(12):1172-7. PubMed ID: 18046122
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Orphan drug development across Europe: bottlenecks and opportunities.
    Heemstra HE; de Vrueh RL; van Weely S; Büller HA; Leufkens HG
    Drug Discov Today; 2008 Aug; 13(15-16):670-6. PubMed ID: 18583178
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Ethics in anorexia nervosa: autonomy, beneficence or responsibility?].
    Figueroa G
    Rev Med Chil; 2008 May; 136(5):659-65. PubMed ID: 18769816
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Defending the duty to research?
    Brassington I
    Bioethics; 2011 Jan; 25(1):21-6. PubMed ID: 19594723
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Bioethics and care: from human rights to quality of care].
    Mitello L; Rufo F
    Prof Inferm; 2005; 58(2):83-8. PubMed ID: 16219177
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The drug industry and clinical research in interwar America: three types of physician collaborator.
    Rasmussen N
    Bull Hist Med; 2005; 79(1):50-80. PubMed ID: 15764827
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Are orphan product program funds underused by nuclear medicine researchers?
    Harby K
    J Nucl Med; 1988 Jun; 29(6):1011-2. PubMed ID: 3373310
    [No Abstract]   [Full Text] [Related]  

  • 53. Ethical responsibilities of health research funders to advance global health justice.
    Pratt B; Hyder AA
    Glob Public Health; 2019 Jan; 14(1):80-90. PubMed ID: 29724152
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An evaluation framework for funding drugs for rare diseases.
    Winquist E; Bell CM; Clarke JT; Evans G; Martin J; Sabharwal M; Gadhok A; Stevenson H; Coyle D
    Value Health; 2012; 15(6):982-6. PubMed ID: 22999151
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ethical Questions Linked to Rare Diseases and Orphan Drugs - A Systematic Review.
    Kacetl J; Marešová P; Maskuriy R; Selamat A
    Risk Manag Healthc Policy; 2020; 13():2125-2148. PubMed ID: 33116992
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The research imperative revisited: considerations for advancing the debate surrounding medical research as moral imperative.
    Wayne K; Glass KC
    Perspect Biol Med; 2010; 53(3):373-87. PubMed ID: 20639606
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A systematic review of moral reasons on orphan drug reimbursement.
    Zimmermann BM; Eichinger J; Baumgartner MR
    Orphanet J Rare Dis; 2021 Jun; 16(1):292. PubMed ID: 34193232
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Does oral infection cause cardiovascular disease? Oral and moral challenges.
    Hofmann BM
    Community Dent Oral Epidemiol; 2011 Oct; 39(5):385-92. PubMed ID: 21521353
    [TBL] [Abstract][Full Text] [Related]  

  • 59. New challenges in translational medicine: transforming the advancement of science into cures. Preface.
    Garaci E; Popoli P
    Ann Ist Super Sanita; 2011; 47(1):5-7. PubMed ID: 21430330
    [No Abstract]   [Full Text] [Related]  

  • 60. Rare diseases: new federal policies.
    Margolis RE
    Healthspan; 1989 May; 6(5):11-3. PubMed ID: 10293290
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.